Side effects typically improve with hydration, slower titration, and nighttime dosing
Calorie reduction and dietary changes can sometimes contribute to lower nutrient intake, which may leave people feeling fatigued or run down
Choosing branded, FDA-approved medications assures quality control and reliable dosage, distinguishing them from compounded alternatives
Gradual Dose Titration: After the first four weeks, the dose is increased to 0.5 mg weekly
Certain GLP-1 formulations have demonstrated cardiovascular benefits in clinical trials, leading to specific FDA approvals: Victoza, Ozempic, and Trulicity are approved for reducing major adverse cardiovascular events in patients with type 2 diabetes and established cardiovascular disease, while Wegovy is approved for cardiovascular risk reduction in adults with established cardiovascular disease and either obesity or overweight